Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Khumalo, Thandokuhle ^a   Reusch, Uwe ^b   Knackmuss, Stefan ^b   Little, Melvyn ^b   Veale, Robin B ^a   Weiss, Stefan F T ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Affimed GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1 IS18; LAMININ 1; LAMININ RECEPTOR; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; IMMUNOGLOBULIN G;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL INVASION; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CELL STRAIN WHCO1; CELL SURFACE; CONTROLLED STUDY; DRUG MECHANISM; ESOPHAGUS CANCER; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN INTERACTION; WESTERN BLOTTING; BREAST TUMOR; ESOPHAGUS TUMOR; FEMALE; IMMUNOLOGY; MALE; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANTIBODIES; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; NEOPLASM INVASIVENESS; RECEPTORS, LAMININ;

EID: 84879191167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066297     Document Type: Article

References (40)

1. Rao NC, Barsky SH, Terranova VP, Liotta LA, (1983) Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 111: 804-808.
2. Lesot H, Kuhl U, Mark K, (1983) Isolation of a laminin-binding protein from muscle cell membranes. EMBO J 2: 861-865.
3. Vana K, Zuber C, Pflanz H, Kolodziejczak D, Zemora G, et al. (2009) LRP/LR as an alternative promising target in therapy of prion diseases, Alzheimer's disease and cancer. Infect Disord Drug Targets 9: 69-80.
4. Hundt C, Peyrin JM, Haik S, Gauczynski S, Leucht C, et al. (2001) Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J 20: 5876-5886.
5. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, et al. (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20: 5863-5875.
6. Scheiman J, Jamieson KV, Ziello J, Tseng JC, Meruelo D, (2010) Extraribosomal functions associated with the C terminus of the 37/67 kDa laminin receptor are required for maintaining cell viability. Cell Death Dis 1: e42.
7. Auth D, Brawerman G, (1992) A 33-kDa polypeptide with homology to the laminin receptor: component of translation machinery. Proc Natl Acad Sci U S A 89: 4368-4372.
8. Sato M, Kinoshita K, Kaneda Y, Saeki Y, Iwamatsu A, et al. (1996) Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40). Biochem Biophys Res Commun 229: 896-901.
9. Nikles D, Vana K, Gauczynski S, Knetsch H, Ludewigs H, et al. (2008) Subcellular localization of prion proteins and the 37 kDa/67 kDa laminin receptor fused to fluorescent proteins. Biochim Biophys Acta 1782: 335-340.
10. Mecham RP, Hinek A, Griffin GL, Senior RM, Liotta LA, (1989) The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. J Biol Chem 264: 16652-16657.
11. Rieger R, Edenhofer F, Lasmezas CI, Weiss S, (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med 3: 1383-1388.
12. Mercurio AM, (1995) Laminin receptors: achieving specificity through cooperation. Trends Cell Biol 5: 419-423.
13. Gauczynski S, Nikles D, El-Gogo S, Papy-Garcia D, Rey C, et al. (2006) The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J Infect Dis 194: 702-709.
14. Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH, (1992) High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 66: 4992-5001.
15. Akache B, Grimm D, Pandey K, Yant SR, Xu H, et al. (2006) The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol 80: 9831-9836.
16. Nadji M, Nassiri M, Fresno M, Terzian E, Morales AR, (1999) Laminin receptor in lymph node negative breast carcinoma. Cancer 85: 432-436.
17. al-Saleh W, Delvenne P, van den Brule FA, Menard S, Boniver J, et al. (1997) Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. J Pathol 181: 287-293.
18. Omar A, Reusch U, Knackmuss S, Little M, Weiss SF, (2012) Anti-LRP/LR-specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells. J Mol Biol 419: 102-109.
19. Sanjuan X, Fernandez PL, Miquel R, Munoz J, Castronovo V, et al. (1996) Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol 179: 376-380.
20. de Manzoni G, Guglielmi A, Verlato G, Tomezzoli A, Pelosi G, et al. (1998) Prognostic significance of 67-kDa laminin receptor expression in advanced gastric cancer. Oncology 55: 456-460.
21. Ozaki I, Yamamoto K, Mizuta T, Kajihara S, Fukushima N, et al. (1998) Differential expression of laminin receptors in human hepatocellular carcinoma. Gut 43: 837-842.
22. Fontanini G, Vignati S, Chine S, Lucchi M, Mussi A, et al. (1997) 67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Clin Cancer Res 3: 227-231.
23. van den Brule FA, Berchuck A, Bast RC, Liu FT, Gillet C, et al. (1994) Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer 30A: 1096-1099.
24. Waltregny D, de Leval L, Menard S, de Leval J, Castronovo V, (1997) Independent prognostic value of the 67-kd laminin receptor in human prostate cancer. J Natl Cancer Inst 89: 1224-1227.
25. Moodley K, Weiss SF, (2013) Downregulation of the non-integrin laminin receptor reduces cellular viability by inducing apoptosis in lung and cervical cancer cells. PLOS ONE 8: e57409.
26. Khusal R, Da Costa Dias B, Moodley K, Penny C, Reusch U, et al. (2013) In Vitro Inhibition of Angiogenesis by Antibodies Directed against the 37 kDa/67 kDa Laminin Receptor. PLOS ONE 8: e58888.
27. Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, et al. (2008) The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep 28: 33-48.
28. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
29. Ardini E, Pesole G, Tagliabue E, Magnifico A, Castronovo V, et al. (1998) The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. Mol Biol Evol 15: 1017-1025.
30. Zuber C, Knackmuss S, Zemora G, Reusch U, Vlasova E, et al. (2008) Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. J Mol Biol 378: 530-539.
31. Bey E, Alexander J, Whitcutt JM, Hunt JA, Gear JH, (1976) Carcinoma of the esophagus in Africans: establishment of a continuously growing cell line from a tumor specimen. In Vitro 12: 107-114.
32. Ardini E, Sporchia B, Pollegioni L, Modugno M, Ghirelli C, et al. (2002) Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res 62: 1321-1325.
33. Liotta LA, Stetler-Stevenson WG, (1991) Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s.
34. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP, (1994) Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335.
35. McKenna DJ, Simpson DA, Feeney S, Gardiner TA, Boyle C, et al. (2001) Expression of the 67 kDa laminin receptor (67 LR) during retinal development: correlations with angiogenesis. Exp Eye Res 73: 81-92.
36. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
37. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
38. Siziopikou KP, Cobleigh M, (2007) The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. Breast 16: 104-107.
39. Zhou L, Xie M, Zhou JQ, Tao L, (2006) 67-kDa laminin receptor in human laryngeal squamous cell carcinoma. Laryngoscope 116: 28-32.
40. Turpeenniemi-Hujanen T, Thorgeirsson UP, Rao CN, Liotta LA, (1986) Laminin increases the release of type IV collagenase from malignant cells. J Biol Chem 261: 1883-1889.